Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brevicillin for antibiotic-associated side effects
NCT06850714Not yet recruiting
- Sponsor
- Liaquat University of Medical and Health Sciences
- Start
- Feb 2025
- Primary completion
- Jun 2025
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Liaquat University of Medical and Health Sciences. Primary endpoint: Change in Antibiotic-Associated Gastrointestinal Symptoms at 15 days. Planned start Feb 2025; status: not yet recruiting.
Beyond the preview
Go deeper on NCT06850714.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06850714.